Furthermore, concomitant E2 and P4 dual therapy markedly increased the protein expression of ERβ, PGR, and Casp-3 alongside cell apoptosis, whereas downregulated the markers of cell proliferation, compared with single hormonal therapies in ovariectomised female rat model of CRC (31). This evidence concerns the gene CASP3 and colorectal carcinoma.